Dose-dependent agonist and antagonist effects of the platelet-activating factor analogue 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine on B lymphocytes.

Abstract

BACKGROUND:

Platelet activating-factor (PAF), an ether-linked phospholipid, is a potent activator of B lymphocyte cell lines. The related ester-linked phospholipid, 1-palmitoyl-2-acetoyl-sn-glycero-3-phosphocholine (PAGPC), is synthesized by tissues important in B-cell development.

OBJECTIVES:

We examined whether PAGPC was capable of influencing immunoglobulin synthesis in B lymphocytes and compared its action with that of PAF. We also examined the interaction of the two mediators as agonists or competitive antagonists.

METHODS:

Ramos, an IgM-secreting immature B-cell line that expresses PAF receptor, was used in these experiments. The effect of PAF, PAGPC, or both mediators together on IgM secretion and anti-IgM-mediated apoptosis was measured.

RESULTS:

Both PAF and PAGPC stimulated IgM production in Ramos cells in a dose-dependent fashion, with PAGPC being approximately three logs less potent than PAF. The effect of both mediators was inhibited by specific PAF receptor antagonists. Preincubation with suboptimal concentrations of PAGPC inhibited the ability of PAF to increase IgM secretion by Ramos cells. Additionally, preincubation with low concentrations of PAGPC prevented PAF from rescuing Ramos cells from apoptosis induced by cross-linking the B-cell receptor with anti-IgM antibodies. PAGPC caused PAF receptor desensitization because displacement of bound PAGPC with high concentrations of bovine serum albumin did not reverse its PAF antagonist effect.

CONCLUSIONS:

PAF and PAGPC are biologically active phospholipids, but PAF is approximately 1000 times more potent. At high concentrations, PAGPC acts similarly to PAF, whereas at lower concentrations, PAGPC acts as a functional PAF antagonist. Because it is secreted at sites of inflammation and allergic reactions, PAGPC may be an endogenous regulator of the effects of PAF.

• Authors: B D Mazer, B Toledano, M Saririan, Y Bastien
• Journal: The Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 102 Issue 2 Pg. 231-7 (Aug 1998) ISSN: 0091-6749 [Print] United States
• PMID: 9723666 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Immunoglobulin M
• Phosphatidylcholines
• Platelet Activating Factor
• 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine

Topics

• Apoptosis
• B-Lymphocytes (drug effects, immunology)
• Dose-Response Relationship, Drug
• Humans
• Immunoglobulin M (metabolism)
• Phosphatidylcholines (pharmacology)
• Platelet Activating Factor (analogs & derivatives, antagonists & inhibitors)
• Tumor Cells, Cultured